Background
Type 2 diabetes mellitus (T2DM) is a common disorder worldwide. Impaired control of glucose levels predisposes to renal dysfunction, detected by a diagnosis of microalbuminuria. Several other risk factors have been identified in the development of microalbuminuria, such as hypertension, smoking, dyslipidemia, and obesity.
Assessment of microalbuminuria and cardiovascular risk factors in type-II diabetic patients who attended the outpatient clinic for the internal medicine department at King Fahd University Hospital, Al-Khobar.
A retrospective cross-sectional and an observational study included data from 2014 to 2022 collected from medical records. Patients with diabetes type-II and aged 18 years were included. The following were reviewed (age, sex, height, weight, body mass index, waist, hip, waist-hip ratio, systolic and diastolic blood pressure, smoking, sedentary lifestyle, diagnosis of dyslipidemia/hypertension, diabetes duration in years) and laboratory results (fasting blood glucose, HbA1C%, estimated glomerular filtration rate, serum creatinine, serum cholesterol, low-density lipoprotein, high-density lipoprotein, and triglycerides). Microalbuminuria was measured by the urine albumin to creatinine ratio and was diagnosed if levels were 30-300 mg/g.
Among 301 studied patients, the prevalence of microalbuminuria was found at 36.8%. The mean age was 57.8 12.6 years, and females were 45%. The mean SD fasting blood glucose was 165.9 71.9 mg/dL, while HbA1C% was 8.8 5.6. Microalbuminuria was significantly associated with age, diabetes duration, systolic blood pressure, HbA1C%, fasting blood glucose, and triglyceride levels (p0.05).
Microalbuminuria in T2DM patients was high in this study, which emphasizes the need for early detection of microalbuminuria. The study suggests the need for effective diabetes control and the prevention of associated cardiovascular risk factors.
Microalbuminuria is an early representative of renal damage or nephropathy in diabetic patients. Microalbuminuria is defined as the increase in urine albumin excretion (30-300 mg/day) or (20-200 mg/day). Urine albumin/creatinine ratio (urine ACR) is the preferred screening approach. Microalbuminuria is diagnosed when urine ACR levels range from 30 to 300 mg/g [1]. Diabetic nephropathyaffects around one-third ofpatients with type 2 diabetes mellitus (T2DM) in Saudi Arabia [2].It has the highest rate when compared to the global incidence of end-stage renal disease caused by diabetic nephropathy [3]. Hence, screening for microalbuminuria in diabetic patients can help in the early detection of diabetic nephropathy and the prevention of further complications.
Hypertension, smoking, hyperglycemia, dyslipidemia, and overweight or obesity are all cardiovascular risk factors that have been associated with the development ofmicroalbuminuria [4]. Glycation of the glomerular basement membrane can occur as a consequence of chronic hyperglycemia and inadequate glycemic management. This, in turn, leads to the progression of diabetic nephropathy as a result of a high glomerular filtration rate and low filtration capacity [5]. Hypertension has been associated with a higher risk of cardiovascular disease. As a result, it causes proteinuria and reduced renal function. Albumin exertion in the urine has been linked to hydrostatic pressure alterations in the afferent glomerulus, increased leakage of the glomerular basal membrane, and poor tubular function in hypertensive patients [6].
Recent studies have concluded that diabetic nephropathy progression is associated with dyslipidemia. High levels of blood total cholesterol (TC), low-density lipoprotein (LDL), serum triglycerides (TG), and low levels of high-density lipoprotein (HDL) characterize diabetic dyslipidemia [7]. Since albuminuria is substantially related to high levels of total cholesterol, the presence of dyslipidemia can be used as an assessment tool for microalbuminuria among patients with T2DM[8]. Cigarette smoking has an independent association with increasing levels of urine albumin. When compared to non-smokers, patients with T2DM who were current smokers had an increased incidence of microalbuminuria per year [9].
Body mass index (BMI) and waist-to-hip ratio (WHR) have been significantly associated with microalbuminuria[10]. The specific pathogenesis regarding obesity-related glomerulopathy is hyperfiltration, which is mediated by excessive protein and salt intake, high blood insulin levels, and increased feedback of the tubuloglomerular component. Central obesity is associated with the secretion of active proteins and proinflammatory cytokines, which play a role in renal injury [11]. Although the previously mentioned metabolic irregularities contribute to renal impairment, there is little evidence regarding the relationship between WHR and microalbuminuria in patients with T2DM as has been established in one study [12]. Hence, studying the association between central obesity and microalbuminuria is one of the main goals of our research. The current study aims to estimate microalbuminuria prevalence and assess the related cardiovascular risk factors among patients with T2DM in Al-Khobar, Saudi Arabia.
This study is a retrospective, cross-sectional study conducted on patients with T2DM who attended the department of internal medicine at King Fahd University Hospital (KFUH) Al-Khobar, Eastern Province, Saudi Arabia from January 2014 to December 2021. Ethical approval from the Imam Abdulrahman Bin Faisal University Institutional Review Board was obtained.
The study comprised 301 patients with T2DM. Inclusion criteria: patients diagnosed with T2DM, aged 18 years, both males and females were included. Exclusion criteria: patientsaged <18 years, previously diagnosed with diabetes type-I, congestive heart failure, chronic kidney disease, or nephrotic syndrome, any patient with a history of steroid use, exposure to radiocontrast agents, active urinary tract infection, fever or pregnancy at the time of urine ACR test was excluded from the study.
Demographic, anthropometric, clinical and laboratorical information for the included patients were reviewed and retrieved from the KFUH database, Quadra Med Computerized Patient Record (QCPR).Past medical history including the duration of diabetes and the diagnosis of hypertensionand dyslipidemia were taken from outpatient clinic visit notes. Age, gender, height, weight, and body mass index (BMI), which was calculated and classified into normal (<25), overweight (25-29.9), obese (30-39.9), and morbidly obese (>40), the circumference of waist and hip, waist-hip ratio, smoking status, sedentary lifestyle (inactive) [13]. The readings included were systolic blood pressure, diastolic blood pressure, and pulse pressure. HbA1C% and fasting blood glucose (FBG) were used for the assessment of glucose control. HbA1C% was classified as controlled (<7%) and uncontrolled (7%), while fasting blood glucose readings were divided into normal (<130 mg/dL) and abnormal ( 130 mg/dL) [14]. Patients lipid profiles for dyslipidemia assessment included total cholesterol, LDL, HDL, and triglycerides. Other important laboratory data for renal profile were serum creatinine and estimated glomerular filtration rate (eGFR), which were calculated by the Modification of Diet in Renal Disease (MDRD) study equation (175 standardized Scr 1.154 age0.203 1.212 (if black) 0.742 (if female)) [15]. eGFR results were classified by the National Kidney Foundation into the following (normal/high 90, mildly decreased 60-80, mildly-moderately decreased 45-59, moderately-severely decreased 30-44) [16]. Microalbuminuria was detected according to hospital policy by using a random spot urine sample. The urine albumin-creatinine ratio was calculated by dividing albumin concentration in milligrams by creatinine concentration in grams. A value of 30-300 mg/g was considered positive microalbuminuria [17]. Statistical analysis was performed by using SPSS Statistics for Windows, version 26.0 (IBM SPSS Statistics for Windows, IBM Corp, Armonk, NY).
Table 1shows the demographic features and associated variable characteristics of all 301 included patients. The mean age was 57.76 12.64 years. Males (55.1%) were slightly more than females in number. The majority of the patients never smoked, while (25.6%) were smokers. Most of the patients (64.1%) had dyslipidemia. About 57% had hypertension, which is less than expected. Sedentary lifestyle was noticed among more than half of the patients. Most of the participants had high BMI readings. The mean waist-hip ratio was 0.9, which is in the high-risk category for metabolic complications. As for the T2DM duration, most of the patients (64.1%) had been diagnosed with T2DM for more than five years. While diastolic and pulse pressure were in the normal range with values of 78.91 11.55 and 55.38 18.21, respectively. The mean systolic blood pressure was high at 136.2 19.43. For blood glucose control, the majority had uncontrolled diabetes (HbA1C of 7%) with a mean level of 8.82 5.58. While fasting blood glucose was abnormal at 66.1%, with a mean level of 165.9 71.94. The mean urine albumin, urine creatinine, and urine ACR were in accordance with microalbuminuria findings. While serum creatinine was within the normal range for most of the patients, about 43.5% had a mildly decreased (60-80) eGFR (mL/min/body surface area (BSA)) with a mean level of 81.11 25.33. More than half of the patients (64.1%) had high cholesterol, LDL, TG levels, and low HDL levels.
Table 2 shows a prevalence of 36.8% for microalbuminuria. Patients with older age, T2DM duration of more than 15 years, elevated systolic BP, high HbA1C (7%), abnormal FBG (130 mg/dL), and high TG levels were found to have a significantly higher percentage of microalbuminuria (p 0.05). Whereas the relationship between microalbuminuria and other patients socio-demographic or disease-related characteristics was found to be non-significant (p 0.05).
Table 3 represents the correlation of urine ACR levels and microalbuminuria with all the numerical variables. A correlation with age, T2DM duration, pulse pressure, FBG, HbA1C, and TG levels was found to be significantly positive (p 0.05).
Table 4 represents the correlation of FBG and HbA1C levels with all the numerical variables. A correlation with T2DM duration, hip-waist-ratio, urine creatinine, urine albumin, total cholesterol, and TG was found to be significantly positive (p 0.05).
Detection of microalbuminuria is one of the crucial steps in managing diabetic patients as it is considered an early sign of renal impairment and subsequent diabetic nephropathy [1]. In this study, 301 diabetic patients were investigated for microalbuminuria and its associated risk factors. The screening for microalbuminuria was conducted using a random sample of urine to test for urine ACR, which is the recommended screening method for microalbuminuria [1]. This studys microalbuminuria prevalence was 36.8%. Previous studies showed a similar result, which was reported in multiple cross-sectional studies in Saudi Arabia ranging from 33.2% to 41.3%, 31.8% to 34.2% in Egypt, and 39% in the DEMAND study globally [17-22].
Despite the similar microalbuminuria prevalence in the current study, there is a possibility of variation in prevalence based on a number of factors related to differences in the population characteristics, microalbuminuria definition, measurement methods, and collection of urine [17]. Gender-specific association with microalbuminuria has been reported in several studies. However, there were a few studies that reported no statistical significance between gender and microalbuminuria [19,22-24]. Our study shows a similar result, in which there was no statistical significance between gender and microalbuminuria. A male predominance in the prevalence of microalbuminuria was reported [8,25,26]. While many other studies reported that the female gender was associated with microalbuminuria [17,18,21,27].
Multiple cross-sectional studies found no association between age and microalbuminuria [17,19,23-26,28]. On the contrary, a few studies reported a statistical significance betweenage and microalbuminuria [8,21]. In the present study, age was observed to be significantly related to microalbuminuria. The present study showed a significant association of longer diabetes duration with the presence of microalbuminuria, which was similar to a previous study [18]. This could be justified by how theperpetuation of hyperglycemia would result in the build-up of glycosylation end products and the presence of protein in urine [5].
Chronic hyperglycemia leads to a decline in renal function by glycation of glomerular basement membranes and stiffening of efferent arterioles. This will adversely increase the glomerular filtration rate, regress filtration capacity and give rise to diabetic nephropathy [5]. HbA1C 7% is an indicator of poor glycemic control. The mean value of HbA1C% for the microalbuminuria group was (8.95 1.79) compared to (8.4 1.84) in patients with normal urine ACR. This study showed a significant association of uncontrolled HbA1C with microalbuminuria similar to a study done in Taif, Saudi Arabia [23]. The mean value of abnormal FBG 130 among patients with microalbuminuria was (176.5 71.87) while for non-microalbuminuria patients it was (159.99 81.63). A significant relationship was noticed among the microalbuminuria group as it was found in other studies [19,20]. Poor glycemic control is a widely known cause of diabetic nephropathy. Our findings were consistent with a previous study [25].
Hypertension is a recognized risk factor for renal impairment [6]. This study has shown a nonsignificant relationship between hypertension diagnosis and microalbuminuria. A similar finding was noted in Alzaid et al., where hypertension had no significance on microalbuminuria [19]. While the contrary was found in several studies [21,23,25,29]. On the other hand, high systolic blood pressure was found to be significantly associated with the presence of microalbuminuria in this study, as seen in a similar study [29]. Increased systolic blood pressure negatively impacts renal function by affecting the systemic arterioles and constant insult to the glomerular filtration membrane resulting in microalbuminuria [30].
Dyslipidemia is a well-studied risk factor for diabetic nephropathy [7]. Previous studies demonstrated a statistical significance regarding the high levels of LDL with the occurrence of microalbuminuria [17,27]. Showail et al. reported a statistical significance between the high levels of total cholesterol, triglycerides, and microalbuminuria [8]. Our study shows a similar result in which high levels of triglycerides were statistically significant with microalbuminuria. However, many studies showed non-statistical significance between lipid profile parameters and microalbuminuria [17,19,23,24,28].
Obesity-related glomerulopathy has been associated with hyperfiltration, which is mediated by excessive protein and salt intake, high blood insulin levels, and increased feedback on the tubuloglomerular component [11]. A few earlier studies demonstrated a statistical significance between BMI and microalbuminuria [17,21,28,26]. Many studies, on the contrary, have not reported statistical significance. This finding was seen in the DEMAND study globally, which was possibly supported by the fact that the Asian population had the lowest BMI despite the highest rates of microalbuminuria [22]. Other studies done in the Middle East showed a similar result of non-significance [8,18,19,23-26]. In the present study, BMI and microalbuminuria did not have a statistically significant relationship.
Central obesity, measured by waist-to-hip ratio, is associated with the secretion of active proteins and proinflammatory cytokines that have a role in renal injury [11]. Based on the literature review, only one study showed a statistical significance between high WHR and microalbuminuria in females with T2DM[12]. Most of the participants in the study were in the higher risk group for WHR. Our study failed to show an association of WHR with microalbuminuria.
Tobacco smoking is one of the independent risk factors for increasing levels of urine albumin [9]. Our study has shown a non-significant relationship with microalbuminuria as seen in other studies [22,24]. On the contrary, many studies reported tobacco use as a risk factor and had linked smoking to the development of microalbuminuria [21,22,25]. Our controversial findings could be attributed to the small sample size and low prevalence of female smokers.
Despite thegood preparation of this study, there were a few limitations. The study participants were from a single hospital in the Al-Khobar area. Due to time restrictions, the sample size was very small to represent the prevalent number of diabetic patients in society. Furthermore, the data collection was clinic-based, so the result was exclusively observed for patients who were following up on a regular basis.
Microalbuminuria is one of the important tests for early renal damage in T2DMpatients. A prolonged duration of diabetes, an increase in age, poor diabetes control, an increased level of triglycerides, and high systolic blood pressure were associated with microalbuminuria. Thus, annual screening for microalbuminuria, maintaining good glycemic control, and managing cardiovascular risk factors can help in reducing microalbuminuria and the progression into diabetic nephropathy. This study encourages regular and early screening of microalbuminuria and the prevention of irreversible kidney damage that results from poor diabetic control. Moreover, the renal injury could be exacerbated by other cardiovascular risk factors such as dyslipidemia and hypertension. This study implements educational material to enhance patient awareness and understanding of their condition and how crucial diabetic control is for reducing complications.
See the original post:
Prevalence of Microalbuminuria and Cardiovascular Risk Factors in Patients With Diabetes Mellitus Type-II in Al-Khobar, Kingdom of Saudi Arabia -...
- TRANSPLANT VIEWS: Stem cell therapy used for diabetic patients [Last Updated On: June 23rd, 2011] [Originally Added On: June 23rd, 2011]
- Diabetes - Video [Last Updated On: November 29th, 2011] [Originally Added On: November 29th, 2011]
- Stem Cell Treatment vs Diet For Diabetes - Video [Last Updated On: January 12th, 2012] [Originally Added On: January 12th, 2012]
- Orgenesis' Sarah Ferber, Ph.D on Using a Diabetes Patient's Own Liver Cells as a Novel Source of Insulin [Last Updated On: June 15th, 2012] [Originally Added On: June 15th, 2012]
- Diabetes drug may kill cancer stem cells, study says [Last Updated On: June 20th, 2012] [Originally Added On: June 20th, 2012]
- Diabetes reversed in mice using stem cells [Last Updated On: June 28th, 2012] [Originally Added On: June 28th, 2012]
- Diabetes Reversed In Mice Thanks To Stem Cell Transplant [Last Updated On: June 28th, 2012] [Originally Added On: June 28th, 2012]
- Diabetes Reversal In Mice Via Stem Cells [Last Updated On: June 28th, 2012] [Originally Added On: June 28th, 2012]
- Diabetes drug makes brain cells grow [Last Updated On: July 6th, 2012] [Originally Added On: July 6th, 2012]
- Diabetes drug helps brain growth, makes mice smarter [Last Updated On: July 6th, 2012] [Originally Added On: July 6th, 2012]
- Diabetes study hit by lack of funds [Last Updated On: September 7th, 2012] [Originally Added On: September 7th, 2012]
- Stem Cells Lupus Testimony Stem Alive - Video [Last Updated On: November 20th, 2012] [Originally Added On: November 20th, 2012]
- Common diabetes drug could fight ovarian cancer [Last Updated On: December 4th, 2012] [Originally Added On: December 4th, 2012]
- Diabetes distresses bone marrow stem cells by damaging their microenvironment [Last Updated On: February 1st, 2013] [Originally Added On: February 1st, 2013]
- Mike Maldonado uses exercise to fight Diabetes and Cancer - Video [Last Updated On: February 22nd, 2013] [Originally Added On: February 22nd, 2013]
- Diabetes : Deep-sea diving tank combined with stem cells to treat condition [Last Updated On: March 12th, 2013] [Originally Added On: March 12th, 2013]
- Diabetes team finds new hormone that could transform care [Last Updated On: April 25th, 2013] [Originally Added On: April 25th, 2013]
- Hormone Shows Potential as Diabetes Treatment in Mice [Last Updated On: April 27th, 2013] [Originally Added On: April 27th, 2013]
- Potential Diabetes Breakthrough - Video [Last Updated On: April 28th, 2013] [Originally Added On: April 28th, 2013]
- Stem Cell Therapy Cures Type 1 Diabetes in Mice [Last Updated On: June 7th, 2013] [Originally Added On: June 7th, 2013]
- John Chick: Giving diabetes the boot [Last Updated On: August 22nd, 2013] [Originally Added On: August 22nd, 2013]
- Scientists Create Personalized Stem Cells, Raising Hopes for Diabetes Cure [Last Updated On: April 28th, 2014] [Originally Added On: April 28th, 2014]
- Stem Cells from a Diabetes Patient [Last Updated On: April 28th, 2014] [Originally Added On: April 28th, 2014]
- Gut Cells May Be Coaxed to Make Insulin for People With Type 1 Diabetes [Last Updated On: July 1st, 2014] [Originally Added On: July 1st, 2014]
- Diabetes tipo 2 Podra ser reversible? [Last Updated On: July 31st, 2014] [Originally Added On: July 31st, 2014]
- James Shapiro: "Cutting Edge Islet and Stem Cell Transplant Therapies in the Clinic for Diabetes" - Video [Last Updated On: August 4th, 2014] [Originally Added On: August 4th, 2014]
- Cure for Type 1 diabetes imminent after Harvard stem-cell breakthrough [Last Updated On: October 9th, 2014] [Originally Added On: October 9th, 2014]
- New diabetes breakthrough 'bigger than the discovery of insulin' [Last Updated On: October 11th, 2014] [Originally Added On: October 11th, 2014]
- A cure for diabetes and awful jokes [Last Updated On: October 12th, 2014] [Originally Added On: October 12th, 2014]
- Stem Cell Success Raises Hopes of Type 1 Diabetes Cure [Last Updated On: October 12th, 2014] [Originally Added On: October 12th, 2014]
- Major step toward diabetes cure - Video [Last Updated On: October 12th, 2014] [Originally Added On: October 12th, 2014]
- Did Scientists Just Cure Type 1 Diabetes? - Video [Last Updated On: October 15th, 2014] [Originally Added On: October 15th, 2014]
- Muscle relaxant may treat rare form of diabetes, scientists find [Last Updated On: November 26th, 2014] [Originally Added On: November 26th, 2014]
- TESTIMONI LAMININE - Ginjal Diabetes dan Komplikasi - Video [Last Updated On: December 3rd, 2014] [Originally Added On: December 3rd, 2014]
- Laminine - Seminar Diabetes - Video [Last Updated On: December 5th, 2014] [Originally Added On: December 5th, 2014]
- Stem cells show promise for reversing type 2 diabetes [Last Updated On: March 19th, 2015] [Originally Added On: March 19th, 2015]
- Vitamin D prevents diabetes and clogged arteries in mice [Last Updated On: March 19th, 2015] [Originally Added On: March 19th, 2015]
- stemtech testimonial diabetes www afastemcell com - Video [Last Updated On: April 29th, 2015] [Originally Added On: April 29th, 2015]
- Afastemcell - testimoni penderita diabetes - Video [Last Updated On: April 29th, 2015] [Originally Added On: April 29th, 2015]
- Diabetes.net Welcome to the Original Diabetes Network [Last Updated On: May 9th, 2015] [Originally Added On: May 9th, 2015]
- Diabetes mellitus [Last Updated On: May 30th, 2015] [Originally Added On: May 30th, 2015]
- Type 2 Diabetes: Everything You Need to Know [Last Updated On: August 6th, 2015] [Originally Added On: August 6th, 2015]
- Diabetes Mellitus Center - Washington, DC - MedicineNet [Last Updated On: August 21st, 2015] [Originally Added On: August 21st, 2015]
- Washington, DC - American Diabetes Association [Last Updated On: August 21st, 2015] [Originally Added On: August 21st, 2015]
- Type 1 Diabetes: Causes, Tests, Symptoms and Treatments [Last Updated On: August 23rd, 2015] [Originally Added On: August 23rd, 2015]
- Type 2 Diabetes: Causes, Symptoms, Prevention, and More [Last Updated On: August 26th, 2015] [Originally Added On: August 26th, 2015]
- Diabetes mellitus - Wikipedia, the free encyclopedia [Last Updated On: August 27th, 2015] [Originally Added On: August 27th, 2015]
- Diabetes | Overview [Last Updated On: August 31st, 2015] [Originally Added On: August 31st, 2015]
- Virginia Diabetes and Endocrinology [Last Updated On: September 7th, 2015] [Originally Added On: September 7th, 2015]
- About Diabetes - American Heart Association [Last Updated On: September 8th, 2015] [Originally Added On: September 8th, 2015]
- Diabetes [Last Updated On: September 12th, 2015] [Originally Added On: September 12th, 2015]
- NIHSeniorHealth: Diabetes - What is Diabetes? [Last Updated On: September 12th, 2015] [Originally Added On: September 12th, 2015]
- Diabetes Symptoms: Common Symptoms of Diabetes [Last Updated On: September 12th, 2015] [Originally Added On: September 12th, 2015]
- Type 2 Diabetes Condition Center - Health.com [Last Updated On: September 12th, 2015] [Originally Added On: September 12th, 2015]
- Diabetes - Symptoms, Diagnosis, Treatment of Diabetes - NY ... [Last Updated On: September 12th, 2015] [Originally Added On: September 12th, 2015]
- Raleigh North Carolina Office of the American Diabetes ... [Last Updated On: September 12th, 2015] [Originally Added On: September 12th, 2015]
- Louisiana Office of the American Diabetes Association [Last Updated On: September 21st, 2015] [Originally Added On: September 21st, 2015]
- Diabetes Basics - What is Diabetes? - Lifeclinic [Last Updated On: October 3rd, 2015] [Originally Added On: October 3rd, 2015]
- Kentucky: Cabinet for Health and Family Services - Diabetes [Last Updated On: October 3rd, 2015] [Originally Added On: October 3rd, 2015]
- Albuquerque-Santa Fe, New Mexico American Diabetes [Last Updated On: October 7th, 2015] [Originally Added On: October 7th, 2015]
- Chicago Illinois Office of the American Diabetes Association [Last Updated On: October 16th, 2015] [Originally Added On: October 16th, 2015]
- Wisconsin Diabetes Prevention and Control Program | Wisconsin ... [Last Updated On: October 25th, 2015] [Originally Added On: October 25th, 2015]
- Diabetes Basics [Last Updated On: July 25th, 2016] [Originally Added On: July 25th, 2016]
- Diabetes: Symptoms, Causes and Treatments - Health News [Last Updated On: July 25th, 2016] [Originally Added On: July 25th, 2016]
- What Can I Eat If I Have Diabetes [Last Updated On: August 1st, 2016] [Originally Added On: August 1st, 2016]
- JDRF Type 1 Diabetes Research Funding and Advocacy [Last Updated On: August 5th, 2016] [Originally Added On: August 5th, 2016]
- children with DIABETES Online Community [Last Updated On: August 5th, 2016] [Originally Added On: August 5th, 2016]
- WHO | Diabetes programme [Last Updated On: August 5th, 2016] [Originally Added On: August 5th, 2016]
- Bridgewater, New Jersey - American Diabetes Association [Last Updated On: August 14th, 2016] [Originally Added On: August 14th, 2016]
- Diabetes Prevention and Control - New Jersey [Last Updated On: August 17th, 2016] [Originally Added On: August 17th, 2016]
- NJDOH - Family Health services - New Jersey [Last Updated On: August 17th, 2016] [Originally Added On: August 17th, 2016]
- Diabetes Australia [Last Updated On: August 18th, 2016] [Originally Added On: August 18th, 2016]
- Diabetes Facts & Information | Joslin Diabetes Center [Last Updated On: August 23rd, 2016] [Originally Added On: August 23rd, 2016]
- Diabetes mellitus type 2 - Wikipedia, the free encyclopedia [Last Updated On: August 23rd, 2016] [Originally Added On: August 23rd, 2016]
- Diabetes - Better Health Channel [Last Updated On: August 23rd, 2016] [Originally Added On: August 23rd, 2016]
- Diabetes Symptoms: American Diabetes Association [Last Updated On: September 1st, 2016] [Originally Added On: September 1st, 2016]
- Types of Diabetes | NIDDK [Last Updated On: September 7th, 2016] [Originally Added On: September 7th, 2016]
- Diabetes mellitus - Wikipedia [Last Updated On: October 26th, 2016] [Originally Added On: October 26th, 2016]
- Diabetes May Be Warning Sign of Pancreatic Cancer - WebMD [Last Updated On: February 6th, 2017] [Originally Added On: February 6th, 2017]
- Roche won't sell diabetes businessit's looking for deals to boost it instead - FierceBiotech [Last Updated On: February 6th, 2017] [Originally Added On: February 6th, 2017]